Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC PatientsIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Journal of Personalized Medicine|2020Cited by 44
Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of GlioblastomaHassan Rahimi, Aurelia Rughetti, Gianluca Trevisi et al.|Journal of Personalized Medicine|2020Cited by 38
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Clinical Cancer Research|2022Cited by 30
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cellsAlessio Ugolini, Marianna Nuti, Ilaria Grazia Zizzari et al.|EBioMedicine|2020Cited by 17
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients.Marianna Nuti, Paolo Marchetti, Ilaria Grazia Zizzari et al.|Journal of Clinical Oncology|2017Cited by 5